Postpartum Breast Cancer: Mechanisms Underlying Its Worse Prognosis, Treatment Implications, and Fertility Preservation

Overview

Journal Int J Gynecol Cancer

Specialties Gynecology & Obstetrics
Oncology

Date 2021 Mar 2

PMID 33649008

Citations 15

Authors

Hanne Lefrere

Liesbeth Lenaerts

Virginia F Borges

Pepper Schedin

Patrick Neven

Frederic Amant

Affiliations

Soon will be listed here.

Abstract

Breast cancers that occur in young women up to 5 to 10 years' postpartum are associated with an increased risk for metastasis and death compared with breast cancers diagnosed in young, premenopausal women during or outside pregnancy. Given the trend to delay childbearing, this frequency is expected to increase. The (immuno)biology of postpartum breast cancer is poorly understood and, hence, it is unknown why postpartum breast cancer has an enhanced risk for metastasis or how it should be effectively targeted for improved survival. The poorer prognosis of women diagnosed within 10 years of a completed pregnancy is most often contributed to the effects of mammary gland involution. We will discuss the most recent data and mechanistic insights of the most important processes associated with involution and their role in the adverse effects of a postpartum diagnosis. We will also look into the effect of lactation on breast cancer outcome after diagnosis. In addition, we will discuss the available treatment strategies that are currently being used to treat postpartum breast cancer, keeping in mind the importance of fertility preservation in this group of young women. These additional insights might offer potential therapeutic options for the improved treatment of women with this specific condition.

Citing Articles

Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study.

Pena-Enriquez R, Bermejo B, Pollan M, Diaz-Chacon A, Jerez Gilarranz Y, Ponce Lorenzo J NPJ Breast Cancer. 2025; 11(1):12.

PMID: 39922815 PMC: 11807221. DOI: 10.1038/s41523-025-00718-x.

Personality traits of women with hereditary risk for breast/ovarian cancer versus obstetric history and cancer preventive behaviors.

Zurawska J, Pieta B, Wilczak M, Wojciechowska M, Rzymski P, Pieczykolan A Sci Rep. 2025; 15(1):3218.

PMID: 39863726 PMC: 11762286. DOI: 10.1038/s41598-025-87657-6.

Gestational breast cancer: distinctive molecular and clinico-epidemiological features.

de la Haba-Rodriguez J, Minguez P, Rojo F, Martin M, Alba E, Servitja S J Mammary Gland Biol Neoplasia. 2024; 29(1):18.

PMID: 39514034 PMC: 11549163. DOI: 10.1007/s10911-024-09571-3.

Association between breastfeeding, mammographic density, and breast cancer risk: a review.

Ye D, Bai X, Xu S, Qu N, Zhao N, Zheng Y Int Breastfeed J. 2024; 19(1):65.

PMID: 39285438 PMC: 11406879. DOI: 10.1186/s13006-024-00672-7.

Immune Cell Contribution to Mammary Gland Development.

Vickers R, Porter W J Mammary Gland Biol Neoplasia. 2024; 29(1):16.

PMID: 39177859 PMC: 11343902. DOI: 10.1007/s10911-024-09568-y.

References

Gaynor N, Crown J, Collins D . Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer. Semin Cancer Biol. 2020; 79:44-57. DOI: 10.1016/j.semcancer.2020.06.016. View

OBrien J, Lyons T, Monks J, Lucia M, Wilson R, Hines L . Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol. 2010; 176(3):1241-55. PMC: 2832146. DOI: 10.2353/ajpath.2010.090735. View

Saha P, Regan M, Pagani O, Francis P, Walley B, Ribi K . Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol. 2017; 35(27):3113-3122. PMC: 5597253. DOI: 10.1200/JCO.2016.72.0946. View

Al-Amri A . Clinical presentation and causes of the delayed diagnosis of breast cancer in patients with pregnancy associated breast cancer. J Family Community Med. 2015; 22(2):96-100. PMC: 4415134. DOI: 10.4103/2230-8229.155383. View

Goddard E, Hill R, Nemkov T, DAlessandro A, Hansen K, Maller O . The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 2016; 7(2):177-187. PMC: 5459606. DOI: 10.1158/2159-8290.CD-16-0822. View

Stein T, Morris J, Davies C, Weber-Hall S, Duffy M, Heath V . Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res. 2004; 6(2):R75-91. PMC: 400652. DOI: 10.1186/bcr753. View

Stensheim H, Moller B, van Dijk T, Fossa S . Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2008; 27(1):45-51. DOI: 10.1200/JCO.2008.17.4110. View

Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S . Genomic signature of parity in the breast of premenopausal women. Breast Cancer Res. 2019; 21(1):46. PMC: 6438043. DOI: 10.1186/s13058-019-1128-x. View

Peccatori F, Azim Jr H, Orecchia R, Hoekstra H, Pavlidis N, Kesic V . Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6:vi160-70. DOI: 10.1093/annonc/mdt199. View

10.

Smith B, R Bellon J, Blitzblau R, Freedman G, Haffty B, Hahn C . Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018; 8(3):145-152. DOI: 10.1016/j.prro.2018.01.012. View

11.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

12.

Lyons T, OBrien J, Borges V, Conklin M, Keely P, Eliceiri K . Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med. 2011; 17(9):1109-15. PMC: 3888478. DOI: 10.1038/nm.2416. View

13.

Takabatake Y, Oxvig C, Nagi C, Adelson K, Jaffer S, Schmidt H . Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer. EMBO Mol Med. 2016; 8(4):388-406. PMC: 4818749. DOI: 10.15252/emmm.201606273. View

14.

Lima S, Kehm R, Swett K, Gonsalves L, Terry M . Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015. JAMA Netw Open. 2020; 3(3):e200929. PMC: 7070232. DOI: 10.1001/jamanetworkopen.2020.0929. View

15.

Martinson H, Jindal S, Durand-Rougely C, Borges V, Schedin P . Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Int J Cancer. 2014; 136(8):1803-13. PMC: 4324053. DOI: 10.1002/ijc.29181. View

16.

Lyons T, Borges V, Betts C, Guo Q, Kapoor P, Martinson H . Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. J Clin Invest. 2014; 124(9):3901-12. PMC: 4153700. DOI: 10.1172/JCI73777. View

17.

Van den Rul N, Han S, van Calsteren K, Neven P, Amant F . Postpartum breast cancer behaves differently. Facts Views Vis Obgyn. 2014; 3(3):183-8. PMC: 3991453. View

18.

Strasser-Weippl K, Ramchandani R, Fan L, Li J, Hurlbert M, Finkelstein D . Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis. Breast Cancer Res Treat. 2014; 149(1):255-61. PMC: 6613825. DOI: 10.1007/s10549-014-3219-9. View

19.

Goddard E, Hill R, Barrett A, Betts C, Guo Q, Maller O . Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments. Int J Biochem Cell Biol. 2016; 81(Pt A):223-232. PMC: 5459605. DOI: 10.1016/j.biocel.2016.10.014. View

20.

Li C, Beaber E, Tang M, Porter P, Daling J, Malone K . Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat. 2012; 137(2):579-87. PMC: 3547981. DOI: 10.1007/s10549-012-2365-1. View